Abstract
In the literature on IgG4-related urinary tract diseases, reports of cases with involvement of the renal pelvis and ureters are increasing. IgG4-related renal pelvic and ureteral lesions accompany extra-renal organ involvement, including IgG4-related type 1 autoimmune pancreatitis, sialadenitis, and orbital disease, and are characterized by the common pathological features of IgG4-related disease (IgG4-RD), including substantial numbers of IgG4-positive plasma cells, storiform fibrosis, and stenosis in the affected organs. Similar to other mucosal organs affected in IgG4-RD, these inflammatory findings are observed within the fibroadipose tissue in the renal hilum and around the ureters. The urothelial epithelium covering the renal pelvis and ureter is preserved. Nodular lesions such as pseudotumors can also form and it is important to differentiate these from malignant tumors. At present, comprehensive diagnostic criteria that include pathological parameters have been proposed for IgG4-RD; however, obtaining diagnostic findings in small biopsy specimens is often challenging. Therefore, the diagnosis can only be rendered following careful consideration of the patient’s clinical, serologic, radiologic, and pathologic features, including the possibility of involvement in other organs.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
1 Introduction
Hamano et al. [1] first reported the presence of elevated serum IgG4 concentrations in autoimmune pancreatitis (AIP) patients as a prototype of IgG4-RD in 2001, and Kamisawa et al. [2] proposed the existence of IgG4-related systemic disease as a new clinicopathologic entity affecting a wide variety of organs in 2003. Increased serum IgG4 levels (>135 mg/dl), the presence of IgG4-positive cells in affected organs, and response to treatment with glucocorticoids are typical features of IgG4-RD, regardless of the organ affected.
In some organs affected by IgG4-RD, however, distinctive forms of pathology can emerge. As an example, IgG4-related kidney disease encompasses renal and renal pelvic lesions, and tubulointerstitial nephritis in the renal cortex is a major, well-described manifestation of the disease. However, the glomeruli (discussed elsewhere), renal pelvis, and ureter can also be affected in IgG4-related renal diseases – the latter primarily in association with retroperitoneal fibrosis. Moreover, pseudotumor-like nodular lesions mimicking urothelial carcinoma can also form in the renal pelvis and ureter. Most reported cases of IgG4-related kidney diseases have a history of prior IgG4-related pancreatitis or sialoadenitis, but cases of patients with IgG4-related urinary tract disease in the absence of other organ involvement have also been reported. In this chapter, renal pelvic and ureteral lesions in IgG4-related diseases have been described.
2 Clinical Features of Renal Pelvic and Ureteral Lesions
Involvement of the renal pelvis and ureter in IgG4-RD appears to be a relatively uncommon disease manifestation, but the extent to which it is underdiagnosed is not clear. Our review of the literature using the search engines for Japanese and English medical articles, ICHUSHI (Web. Japana Centra Revuo Medicina) and PubMed, respectively, revealed a total of 35 reported cases of such involvement [3–30], including a renal pelvic case that was experienced by our group (Case 12). These cases are summarized in Table 13.1. In addition, a review article on IgG4-related renal disease has recently been reported [31]. The age of patients ranged from 39 to 84 years, and older patients as well as males constituted the majority. Most of the cases consisted of isolated renal pelvic or ureter involvement. However, continuous distributions from the renal pelvis to the ureter as well as inflammatory pseudotumors were also observed in some cases. Moreover, synchronous and metachronous involvement was found in bilateral pelvises and ureters.
3 Renal Pelvic Lesions
The renal pelvic lesions of IgG4-RD are visualized radiologically as thickening of the renal pelvic wall without luminal irregularity or tumorous lesions in the renal hilum. As shown in Figs. 13.1, 13.2, and 13.3, unlike renal pelvic mucosal lesions, the lesions in IgG4-related kidney diseases are recognizable as nonspecific nodular lesions within the fibroadipose tissue of the renal hilum. The histology shows dense lymphoplasmacytic infiltration with lymphoid follicles and loss of adipose tissue within the renal hilum. Fibrosis with hyalinization and storiform fibrosis are found (Fig. 13.3f). However, the degree of sclerosing changes is comparatively milder than that observed in autoimmune pancreatitis, a prototypical form of IgG4-RD; furthermore, some cases show only a prominent inflammatory change with relatively few fibrotic changes (Case 11 in Table 13.1) [13]. Similar to the histological characteristics of other affected organs in IgG4-RD, eosinophilic infiltration, obliterative phlebitis (Fig. 13.1e), and perineural inflammatory infiltration (Fig. 13.3d) are also observed in some cases. This infiltration extends beyond the subepithelial layer of the renal pelvic urothelial mucosa; however, involvement of the urinary epithelial layer and epithelial injury are not prominent. Similar to IgG4-related autoimmune pancreatitis and sclerosing cholangitis, therefore, the epithelial layer is well-preserved without any erosive changes. This lack of epithelial layer involvement underlies the general difficulties in obtaining valuable pathological information from superficial mucosal specimens by renal pelvic biopsy procedures. However, specimens from most of the patients show an absence of inflammation extending into the renal parenchyma, with a clear border between the renal pelvic pathology and renal parenchyma. Exceptions to the rule occur, however, as some cases of inflammatory invasion of the renal parenchyma (Fig. 13.3) and interstitinal nephritis were observed (Case 3 in Table 13.1) [5].
Immunohistochemical staining for IgG4 has revealed substantial numbers of IgG4-positive plasma cells within inflammatory lesions, even though IgG4 normally comprises only 3–6 % of the total circulating IgG in adults [1]. In cases with prominent lymphoid follicle formation, IgG4-positive cells tend to be localized in the interfollicular area, with several IgG4-positive cells scattered in the germinal centers of lymphoid follicles. As expected, these cases fulfill the comprehensive pathological diagnostic criteria for IgG4-RD [32], based on an IgG4:total IgG ratio >0.40 and the presence of >10 cells/high powered field in the biopsy sample. The predominance of IgG4-positive cells instead of IgG1-positive cells also supports the diagnosis of IgG4-related diseases (Fig. 13.2e, f).
4 Ureteral Diseases
Ureteral involvement in IgG4-RD has been found in 42 % of the IgG4-related retroperitoneal fibrosis cases [13]. In some patients, either renal pelvic involvement or ureteral lesions (either unilateral or bilateral) are also observed. Regardless of the involvement of other organs, IgG4-RD of the ureter is characterized by the thickening of ureteral wall or the presence of nodular lesions involving the affected ureter. These are usually associated with hydronephrosis resulting from ureteral stenosis of the affected portion. Therefore, in most cases of IgG4-related ureteral disease, the initial presentation is hydronephrosis associated with retroperitoneal fibrosis or renal dysfunction with unknown etiology. The diagnosis of IgG4-RD may be suspected on the basis of an increased serum IgG4 concentration and/or hypocomplementemia, the latter of which is often observed with intrinsic renal involvement by IgG4-RD [33]. The diagnosis must be established by biopsy of an affected organ.
IgG4-related ureteral disease displays the common pathological features of other IgG4-RD manifestations: in addition to marked lymphoplasmacytic infiltration, eosinophilic infiltration and storiform fibrosis are also observed in the lesions. Advanced fibrosis eventually results in ureteral sclerosis that in turn induces ureteral stenosis and obstruction. Lymphoid follicle formation can also be detected, albeit to a lesser extent than that observed in renal pelvic lesions. The extension of the inflammatory reaction into the adipose tissue around affected organs is an important feature of IgG4-RD, including autoimmune pancreatitis, reflecting their characteristic radiological findings. Similarly, periureteral fibroadipose tissue as well as the ureteral wall harbor inflammatory and fibrosclerotic reactions (Fig. 13.4a). In some cases, these reactions extend into the lesions of retroperitoneal fibrosis. Immunohistochemical staining for IgG1 and IgG4 reveals a predominantly IgG4-positive plasma cell infiltration in this disease (Fig. 13.4d, e).
5 Diagnosis
The diagnosis of IgG4-related renal pelvic and ureteral diseases is relatively easy and is based on the common clinicopathological features of IgG4-RD in cases where there is either a concurrent or preceding diagnosis of IgG4-RD in other organs, such as the pancreas or the salivary glands. However, if the initial lesions are within the renal pelvis or ureters with no overt involvement of other organs, differentiation of the lesions from malignant masses or stenosis in the affected area is crucial. Moreover, inflammatory pseudotumors not related to IgG4, inflammatory myofibroblastic tumors [15], and Cattleman’s disease in cases with limited fibrosclerosis [13] should also be considered in the differential diagnosis.
Increased serum IgG4 levels and infiltration of IgG4-positive plasma cells are important in the diagnosis of IgG4-related renal pelvic and ureteral diseases. According to the current comprehensive diagnostic criteria for IgG4-RD [32], elevated serum levels of IgG4 (≥135 mg/dl) and predominantly IgG4-positive plasma cell infiltration (≥10 cells/high-power field with an IgG4-positive:total IgG-positive plasma cell ratio of ≥40 %) are essential to securing the IgG4-RD diagnosis. However, as mentioned above, biopsy specimens from the surface of the renal pelvis or the ureteral mucosa usually fail to demonstrate the characteristic features of IgG4-RD. Although the number of IgG4-positive cells that can be detected in small renal pelvic and ureteral specimens is not known, the biopsy of stenotic lesions is recommended, as demonstrated in Case 13 in Table 13.1 where the IgG4-related ureteral disease was diagnosed by ureteral biopsy [14].
To complicate matters, IgG4-related ureteral disease in association with carcinoma in situ (urothelial carcinoma) [18], as seen with Case 21 in Table 13.1, raises the possibility of ureteral cancer preceding IgG4-RD. Although the infiltration of numerous IgG4-bearing plasma cells is important for the pathogenesis of IgG4-RD, patients with pancreatic adenocarcinomas accompanied by IgG4 infiltration into the cancerous area and/or elevated serum IgG4 levels [33–37], as well as patients with pancreatic or biliary malignancies arising in the setting of IgG4-RD [35, 38, 39], have been reported. However, no cause-and-effect relationship between IgG4-RD and cancer has been demonstrated. It is imperative to examine the role of IgG4 in renal pelvic and ureteral cancers. Further, potential malignancies must be excluded rigorously in patient undergoing evaluation for possible IgG4-RD. Renal pelvic and ureteral biopsies and cytological examinations are essential to the exclusion of malignancies.
6 Conclusion
Renal pelvic and ureteral lesions are part of the IgG4-RD spectrum and are essential to distinguish from malignancy. In this chapter, we reviewed IgG4-related renal pelvic and ureteral diseases in the light of previous reports. Consequently, these manifestations are often associated with IgG4-RD in other organs, elevations of serum IgG4 concentrations, and substantial numbers of IgG4-positive plasma cells in the affected tissues.
References
Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344(10):732–8.
Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38(10):982–4.
Kawaguchi M, Kobori Y, Nakshima T, Shimada M. A case of IgG4-related localized retroperitonitis mimicking renal pelvic tumor (in Japanease with English abstract). Hinyokika Kiyo. 2009;55(9):587.
Kuroda N, Nakamura S, Miyazaki K, Inoue K, Ohara M, Mizuno K, et al. Chronic sclerosing pyelitis with an increased number of IgG4-positive plasma cells. Med Mol Morphol. 2009;42(4):236–8.
Tsukui K, Masunaga K, Kasuya Y, et al. IgG4-related sclersosing disease radiologically diagnosed as right renal pelvic and uteral tumor (in Japanease with English abstract). Hinyoki Geka. 2012;25:1115.
Kobayashi T, Yamaguchi A, Yamamoto S, Kimura H, Masaki K, Hirata M, et al. Mass-forming autoimmune pancreatitis caused after resection of an IgG4-related renal pelvic lesion (in Japanese with English abstract). Nihon Shokakibyo Gakkai Zasshi (Jpn J Gastroenterol). 2011;108(10):1752–60.
Sato T, Kobayashi F, Kumano S, et al. A case of IgG4-related disease suspecting malignant renal pelvic tumor (in Japanese). Jpn J Urol. 2008;99(2):282.
Tsuboyama N, Kin T, Nakamoto A, et al. A case of IgG4-related sclerosing disease with the initial lesion of periureteral imflammatory pesudotumor (in Japanese). Jpn J Radiol. 2011;29(SupplI):45.
Araki A, Nakano A, et al. A case of inflmammatory pseutotumor around renal pelvis and ureter suspecting IgG4-related disease (in Japanese). Proc Jpn Soc Pathol. 2008;97(1):344.
Seno Y, Atarashi R, Tsushima T, et al. A case of IgG4-related disease with wall thicking of renal pelvis and mass forming in renal hilus (in Japanese). Nishinihon J Urol. 2009;71(8):433.
Tanuma Y, Habiro A, Kubo K, Okamoto T. A case of bilateral renal pelvic IgG4-related diseases (in Japanese). Jpn J Urol. 2010;101(2):490.
Satake Y, Takeuchi A, Abe Y, et al. A case of IgG4-related pseudotumor of renal pelvis and ureter (in Japanese). Hinyoki Geka. 2012;25:1116.
Miyazaki M, Haratake J, Takano N, et al. IgG4-related disease in renal hilus lacking sclerosing change (in Japanese). Shindan Byori. 2009;26(2):111–4.
Yazawa A, Ohara R, et al. Two cases of systemic IgG4-related plasmacytic syndrome(SIPS) with ureteral thickrning (in Japanese). Hinyoki Geka. 2010;23:517.
Abe H, Morikawa T, Araki A, Shima T, Nakatsu H, Fukayama M, et al. IgG4-related periureteral fibrosis presenting as a unilateral ureteral mass. Pathol Res Pract. 2011;207(11):712–4.
Hamano H, Kawa S, Ochi Y, Unno H, Shiba N, Wajiki M, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002;359(9315):1403–4.
Kamisawa T, Chen PY, Tu Y, Nakajima H, Egawa N. Autoimmune pancreatitis metachronously associated with retroperitoneal fibrosis with IgG4-positive plasma cell infiltration. World J Gastroenterol. 2006;12(18):2955–7.
Kim SA, Lee SR, Huh J, Shen SS, Ro JY. IgG4-associated inflammatory pseudotumor of ureter: clinicopathologic and immunohistochemical study of 3 cases. Hum Pathol. 2011;42(8):1178–84.
Zhang H, Ren X, Zhang W, Yang D, Feng R. IgG4-related kidney disease from the renal pelvis that mimicked urothelial carcinoma: a case report. BMC Urol. 2015;15:44.
Tsuzaka Y, Ookubo K, Sugiyama K, Morimoto H, Amano H, Oota N, et al. IgG4-related kidney disease: a long-term follow up case of pseudotumor of the renal pelvis (in Japanese with English abstract). Nihon Hinyokika Gakkai Zasshi. 2014;105(2):51–5.
Inoue S, Takahashi C, Hikita K. A case of IgG4-related retroperitoneal fibrosis from the renal pelvis mimicking bilateral hydronephrosis. Urol Int. 2016;97:118–22.
Nomura H, Kinjyo T, Oida T, Yoneda S, Takezawa K, Tei N, et al. IgG4-related idiopathic segmental ureteritis which was difficult to distinguish from ureteral cancer: a case report (in Japanese with English abstract). Hinyokika Kiyo. 2013;59(3):167–70.
Takata M, Miyoshi M, Kohno M, Ito M, Komatsu K, Tsukahara K. Two cases of IgG4-related systemic disease arising from urinary tract (in Japanese with English abstract). Hinyokika Kiyo. 2012;58(11):613–6.
Yoshino T, Moriyama H, Fukushima M, Sanda N. A case of IgG4-related retroperitoneal fibrosis mimicking renal pelvic cancer. Urol Int. 2013;90(3):365–8.
Minato N, Takayama H, Mukai M, Miyagawa Y, Tsujihata M, Nonomura N, et al. A case report of retroperitoneal fibrosis associated with IgG4-related sclerosing disease (in Japanese with English abstract). Hinyokika Kiyo. 2010;56(7):371–5.
Wang Y, Chen X, Luo R, Wang H, Wang G, Hou Y, et al. IgG4-related systemic disease mimicking renal pelvic cancer: a rare case. World J Surg Oncol. 2014;12:395.
Moriarty MA, Dahmoush L, Nepple KG. IgG4 related disease of the ureter (inflammatory pseudotumor). J Urol. 2014;191(4):1126–7.
Dyer A, Sadow PM, Bracamonte E, Gretzer M. Immunoglobulin G4-related retroperitoneal fibrosis of the pelvis. Rev Urol. 2014;16(2):92–4.
Kim S, Kim TG, Choi SK, Kim MJ, Min GE, Lee HL, et al. Immunoglobulin g4-related systemic sclerosing disease: a case involving the ureter and kidney. Kor J Urol. 2013;54(3):209–11.
Marando A, D’Ambrosio G, Catanzaro F, La Rosa S, Sessa F. IgG4-related disease of the ureter: report of two cases and review of the literature. Virchows Arch. 2013;462(6):673–8.
Kuroda N, Nao T, Fukuhara H, Karashima T, Inoue K, Taniguchi Y, et al. IgG4-related renal disease: clinical and pathological characteristics. Int J Clin Exp Pathol. 2014;7(9):6379–85.
Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol/Jpn Rheum Assoc. 2012;22(1):21–30.
Raina A, Krasinskas AM, Greer JB, Lamb J, Fink E, Moser AJ, et al. Serum immunoglobulin G fraction 4 levels in pancreatic cancer: elevations not associated with autoimmune pancreatitis. Arch Pathol Lab Med. 2008;132(1):48–53.
Ghazale A, Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol. 2007;102(8):1646–53.
Kamisawa T, Chen PY, Tu Y, Nakajima H, Egawa N, Tsuruta K, et al. Pancreatic cancer with a high serum IgG4 concentration. World J Gastroenterol. 2006;12(38):6225–8.
Dhall D, Suriawinata AA, Tang LH, Shia J, Klimstra DS. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis. Hum Pathol. 2010;41(5):643–52.
Harada K, Shimoda S, Kimura Y, Sato Y, Ikeda H, Igarashi S, et al. Significance of immunoglobulin G4 (IgG4)-positive cells in extrahepatic cholangiocarcinoma: molecular mechanism of IgG4 reaction in cancer tissue. Hepatology. 2012;56(1):157–64.
Motosugi U, Ichikawa T, Yamaguchi H, Nakazawa T, Katoh R, Itakura J, et al. Small invasive ductal adenocarcinoma of the pancreas associated with lymphoplasmacytic sclerosing pancreatitis. Pathol Int. 2009;59(10):744–7.
Oh HC, Kim JG, Kim JW, Lee KS, Kim MK, Chi KC, et al. Early bile duct cancer in a background of sclerosing cholangitis and autoimmune pancreatitis. Intern Med (Tokyo, Japan). 2008;47(23):2025–8.
Acknowledgments
The author is very grateful to the following pathologists for generously donating surgical samples: Dr. Kuroda, N (Kochi Red Cross Hospital, Department of Diagnostic Pathology, Kochi, Japan), Dr. Abe, H (Department of Pathology, Graduate school of Medicine, The University of Tokyo, Tokyo, Japan), Dr. Niwa, H (Ishikawa Prefectural Central Hospital, Department of Pathology, Kanazawa, Japan), Dr. Hiramatsu, R (Toranomon Hospital, Tokyo, Japan), Dr. Fujii, T (Department of Pathology, Toranomon Hospital, Tokyo, Japan), and Dr. Kawano, M (Kanazawa University Hospital, Division of Rheumatology, Kanazawa, Japan).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Japan
About this chapter
Cite this chapter
Harada, K., Ubara, Y. (2016). IgG4-Related Kidney Diseases and Conditions: Renal Pelvic and Ureteral Diseases. In: Saito, T., Stone, J., Nakashima, H., Saeki, T., Kawano, M. (eds) IgG4-Related Kidney Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55687-9_13
Download citation
DOI: https://doi.org/10.1007/978-4-431-55687-9_13
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-55686-2
Online ISBN: 978-4-431-55687-9
eBook Packages: MedicineMedicine (R0)